走向一个新的标准:可切除胰腺癌的序列多剂新辅助化疗
Artur Rebelo1, Thomas Seufferlein2, Jorg Kleeff1
1Department of Visceral, Vascular and Endocrine Surgery, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
对于切除的胰腺癌,手术前的新辅助化疗改善了生存率. 使用顺序的gemcitabine/nab-paclitaxel,其次是mFOLFIRINOX的新方法为患者提供了比前期手术更好的选择.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 可切除胰腺癌的标准治疗包括前期手术,随后是辅助疗法.
- 优化新辅助治疗策略对于改善患者的治疗结果至关重要.
研究的目的:
- 为了评估与可切除胰腺癌的前期手术相比,连续的新辅助化疗方案的疗效.
主要方法:
- 一个随机试验,比较了顺序的新辅助剂格姆西塔/纳布-帕克利塔塞尔,其次是mFOLFIRINOX,前期手术和辅助疗法.
主要成果:
- 与前期手术手臂相比,顺序的新辅助方法显著改善了无事件生存率.
- 这表明新辅助化疗在可切除胰腺癌中的潜在益处.
结论:
- 一个连续的新辅助化疗策略,包括gemcitabine/nab-paclitaxel和mFOLFIRINOX,证明了可切除胰腺癌的优异无事件生存率.
- 这些发现支持在治疗胰腺癌时,在手术前转向新辅助治疗.
更多相关视频
13:56Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
Published on: August 14, 2021
08:12Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
Published on: February 2, 2022
相关概念视频
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
